In the News

Russo Partners works at the intersection of science, medicine, and media. The stories below reflect the conversations we help shape covering breakthroughs in biopharma, digital health, healthcare, and beyond.

Labiotech

April 17, 2026

Therapy for brain injuries in infants bags funding: is the first HIE drug on the way?

The fifth leading cause of death globally in children under the age of five, HIE is a type of brain damage…

For more

Inside Precision Medicine

April 15, 2026

It’s HAMMR Time: Duracyte Launches with “Living Pharmacy” Platform

The Houston startup is advancing its Hybrid Advanced Molecular Manufacturing Regulator, an implantable bioreactor that produces biologic drugs in patients….

For more

ABC 7 Chicago

April 14, 2026

New drug created at Northwestern helps pancreatic cancer patients live longer, oncologist says

A drug trial at Northwestern Medicine offers hopeful results to those with pancreatic cancer. GI Oncologist Dr. Deva Mahalingam is…

For more

TIME

April 14, 2026

Two New Drugs Offer Hope for Pancreatic Cancer

Pancreatic cancer is one of the most challenging diseases to treat, and while survival rates have improved since the 1970s, they have…

For more

FOX 5 Las Vegas

April 7, 2026

Former Bengal Ickey Woods bringing celebrity golf tourney to Las Vegas for asthma charity

Former NFL player and Cincinnati Bengals fan favorite Ickey Woods is coming to Las Vegas on Monday, April 13, to…

For more

BioWorld

April 9, 2026

Ibio’s IBIO-600 cleared to enter clinic in Australia for obesity

Ibio Inc. has received clinical trial notification (CTN) acknowledgement from Australia’s Therapeutic Goods Administration (TGA), as well as Human Research…

For more